References
- Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515–518.
- Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57:1308–1318.
- Quenot JP, Luyt CE, Roche N, et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy. Ann Intensive Care. 2013;3:21.
- Davies J. Procalcitonin. J Clin Pathol. 2015;68:675–679.
- Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta. 2020;505:190–191.
- Schuetz P, Chiappa V, Briel M, et al. Procalcitonin Algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171:1322–1331.
- Soni NJ, Samson DJ, Galaydick JL, et al. Procalcitonin-guided antibiotic therapy. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012.
- EP15-A3. User verification of precision and estimation of bias-approved guideline. Wayne (PA): Clinical and Laboratory Standards Institute; 2014.
- EP17-A2. Protocols for determination of limits of detection and limits of quantitation. Wayne (PA): Clinical and Laboratory Standards Institute; 2004.
- Delgado JA, Morell-Garcia D, Bauça JM. Hemolysis interference studies: the particular case of sodium ion. EJIFCC. 2019;30:25–34.
- Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135–160.
- ISO 5725-6. Accuracy (trueness and precision) of measurement methods and results. Part 6: use in practice of accuracy values. 1994.
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174.
- Guggenmoos-Holzman I. The meaning of kappa: probabilistic concepts of reliability and validity revisited. J Clin Epidemiol. 1996; 49:775–782.
- Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem. 2012;45:464–469.
- Dupuy AM, Né M, Bargnoux AS, et al. Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay. Clin Biochem. 2017;50:248–250.
- Soh A, Binder L, Clough M, Hernandez MH, et al. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems. Pract Lab Med. 2018;12:e00110.
- Dipalo M, Guido L, Micca G, et al. Multicenter comparison of automated procalcitonin immunoassays. Pract Lab Med. 2015;2:22–28.
- Chambliss AB, Hayden J, Colby JM. Evaluation of procalcitonin immunoassay concordance near clinical decision points. Clin Chem Lab Med. 2019;57:1414–1421.